The looming co-epidemic of TB-Diabetes

Diabetes, an immunocompromised state, significantly increases the risk that person will develop tuberculosis (TB) infection. A new report released by The International Union Against Tuberculosis and Lung Disease Read More


Helpful Instructional Video on FASH (“Focused Assessment with (Ultra)Sonography for TB-HIV”)

I recently completed a stretch of Night Float during residency and, in the rare lulls, found myself trying to brush up or learn the basics Read More

World map

TB detection innovation holds potential to reduce infection’s spread

Sputum samples containing tuberculosis bacteria fluoresce. Jeffrey D. Cirillo A newly discovered way of testing people for tuberculosis (TB) dramatically cuts the time it takes for a diagnosis to under an hour. The development by chemist Jianghong Rao of Stanford and microbiologist Jeffrey Cirillo of Texas A&M Health Science Center could not only make TB … Continue reading →


Experts Warn Of TB-Diabetes Co-Infection

Reuters: Experts sound alarm as diabetes fuels cases of TB “Cases of tuberculosis are set [to] accelerate worldwide unless action is taken to curb diabetes, a chronic condition that weakens the immune system and triples the risk a person will develop the lung disease, health experts warned on Wednesday…” (Hirschler, 10/29).

The looming co-epidemic of TB-Diabetes


Diabetes, an immunocompromised state, significantly increases the risk that person will develop tuberculosis (TB) infection. A new report released by The International Union Against Tuberculosis and Lung Disease Read More

Improved Data Collection Shows More TB Cases Worldwide, But Progress Made In Curbing Disease,…

Media sources report on the WHO’s annual tuberculosis report, which shows progress against TB but says more effort must be put into tracking and treating those who are infected. Agence France-Presse: Big strides made in fighting TB, says WHO “The known tally of people with tuberculosis rose last year but overall ‘major progress’ is being…More

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis — NEJM.

WHO Releases Annual Global TB Report

World Health Organization: Global tuberculosis report 2014 The WHO released its annual global report on tuberculosis (TB), which “provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional, and country levels using data reported by over 200 countries that account for…More

Ebola Sparks Debate On How Donors Fund Global Health, Reuters Reports

Reuters: Ebola may change how aid is spent on health care in Africa “The Ebola outbreak in West Africa has exposed major gaps in development aid, prompting a rethink of the balance between building health systems and tackling specific diseases like AIDS, malaria, and tuberculosis…” (Wroughton, 10/13).

Tackling TB In India Requires Both Public, Private Sector Engagement

The Hindu: Fighting India’s silent epidemic Soumya Swaminathan, director of the National Institute for Research in Tuberculosis in Chennai, and Chapal Mehra, New Delhi-based writer “Over 60 percent of all Indians seek health care in the private sector, according to India’s last National Family Health Survey. … Even though parallel providers of health services, the…More

Blog Post Outlines Actions Needed To Continue Progress On MDG 6 As Target Date Approaches

Health Affairs Blog: 500 Days And Counting: Critical Steps In The Countdown To Achieving MDG 6 Deb Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, and Peter Yeo, vice president of public policy and advocacy at the United Nations Foundation, outline actions needed to continue to make progress on MDG…More

GSK and NewLink boost capacity to make Ebola vaccines

Pharmaceutical companies GlaxoSmithKline and NewLink Genetics say they are increasing their efforts to make Ebola vaccines.

Tuberculosis Abscess of the Chest Wall


Standardization of a TaqMan-Based Real-Time PCR for the Detection of Mycobacterium…


Treatment Outcomes for Patients with Multidrug-Resistant Tuberculosis in Post-Earthquake…


Novel Financing Mechanisms Needed To Improve Access To Multidrug-Resistant TB Treatment

PLOS Medicine: Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment Thomas Hwang of Harvard University and the Blackstone Group, and Salmaan Keshavjee of Harvard University and Partners in Health, explore issues surrounding scaling up access to treatment for multidrug-resistant tuberculosis, including novel financing structures (9/30).

The Atlantic Examines Challenges Surrounding TB Vaccine Development

The Atlantic: Toward an Effective Tuberculosis Vaccine “…While we have vaccines to thank for the decline of global diseases like measles and smallpox, vaccination’s role in the worldwide battle against TB has been comparatively minimal. … So, what is it about a TB vaccine that’s had science stymied for over a century?…” (Shure, 9/26).

Older Posts »